Form 4: Standard BioTools CEO Sells Shares to Cover Tax Obligations

Michael Egholm, CEO of Standard BioTools Inc., disposed of 102,564 shares of common stock on April 8, 2024, to cover tax obligations related to vesting performance-based restricted stock units.

Summary

• On April 8, 2024, Michael Egholm, the President and CEO of Standard BioTools Inc., disposed of 102,564 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations arising from the vesting of performance-based restricted stock units (RSUs) granted on April 11, 2023.
• The shares were sold at a price of $2.71 per share.
• Following the transaction, Egholm directly owns 531,592 shares of Standard BioTools Inc.

Sentiment

Score: 5

Explanation: This is a neutral event. It reflects a standard transaction for covering tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to vesting equity awards.

Stakeholder Impact

• The sale of shares by the CEO could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.

Key Dates